Approval ratings for the coronavirus response from President Trump and the Centers for Disease Control are dipping, a new poll released by Morning Consult on Monday shows.
Of those surveyed, 49 percent approved of the job Trump is doing to prepare the U.S. for the virus, which is down 7 percent from the previous week's poll and 12 percent from earlier this month. His disapproval rating, meanwhile, jumped up from 27 percent to 37 percent.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Morning Consult notes the decline is likely a result of news about local outbreaks in the country, which include multiple deaths, as well as reports about false negative tests.
The poll, conducted between Feb. 28 and March 1, surveyed 1,997 registered voters. The margin of error is two percentage points. Read more at Morning Consult.
-
Storyteller: a ‘fitting tribute’ to Robert Louis StevensonThe Week Recommends Leo Damrosch’s ‘valuable’ biography of the man behind Treasure Island
-
Is Europe finally taking the war to Russia?Today's Big Question As Moscow’s drone buzzes and cyberattacks increase, European leaders are taking a more openly aggressive stance
-
How coupling up became cringeTalking Point For some younger women, going out with a man – or worse, marrying one – is distinctly uncool
-
Obesity drugs: Will Trump’s plan lower costs?Feature Even $149 a month, the advertised price for a starting dose of a still-in-development GLP-1 pill on TrumpRx, will be too big a burden for the many Americans ‘struggling to afford groceries’
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
Can TrumpRx really lower drug prices?Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
Why are autism rates increasing?The Explainer Medical experts condemn Trump administration’s claim that paracetamol during pregnancy is linked to rising rates of neurodevelopmental disorder in US and UK
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
